Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2023-10-17 00:00:00 ET · period of report 2023-10-16 · accession 0001823239-23-000085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-17 | 2023-10-16 | MRVI | MARTIN WILLIAM E. III | CEO | F - Tax | $7.54 | -66.2K | 281.9K | -19% | -$499.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-10-16 | F | D | 66,197 | $7.54 | 281,858 | D | — | — | (F1) Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. |